期刊文献+

愈肾方对阿霉素肾病模型大鼠蛋白尿的影响 被引量:1

Effect of Yushen Formula on Proteinuria in Adriamycin Nephropathy Model Rats
原文传递
导出
摘要 目的观察愈肾方对阿霉素(ADR)肾病模型大鼠的干预作用及其可能机制。方法 50只SD大鼠随机分为空白组、模型组、激素组、愈肾方大剂量组、愈肾方小剂量组,每组10只。除空白组外,其余各组大鼠均尾静脉注射2次(间隔7天)ADR建立肾病模型。末次注射后第3天,激素组给予醋酸泼尼松片9.0mg/kg灌胃,愈肾方大、小剂量组分别给予愈肾方39.6g/kg、19.8g/kg灌胃,空白组和模型组均给予等量饮用水,各组共灌胃21天。比较各组大鼠24h尿量及尿蛋白含量、肾功能、血脂、总蛋白(TP)、肾脏组织内皮素1(ET-1)及肾脏组织病理变化。结果与模型组比较,激素组和愈肾方大、小剂量组24 h尿量增加,愈肾方大、小剂量组尿蛋白含量减少(P<0.05或P<0.01)。与空白组比较,各组大鼠肾功能、血脂均显著增高,TP显著降低(P<0.05或P<0.01)。与空白组比较,模型组大鼠肾组织ET-1染色强度升高,激素组与模型组无显著差异,愈肾方大、小剂量组中ET-1染色强度降低。结论愈肾方可明显降低ADR肾病模型大鼠尿蛋白,可有效修复肾小球结构、足细胞及裂孔隔膜形态,其机理可能与减少ET-1的分泌有关。 Objective To observe the therapeutic effect and possible mechanism of Yushen Formula (formula to treat nephropathy, 愈肾方) for adriamycin nephropathy (AN) in rats. Methods Fifty SD rats were randomized in- to blank group, model group, hormone group and Yushen Formula large-dose group and small-dose groups, with 10 in each. The nephropathy models were established by tail vein injection of adriamycin (ADR) twice (7 days interval) in all groups except the blank group. On the 3rd day after the last injection, the hormone group was gavaged with 9.0 mg/kg prednisone tablets, Yushen Formula large-dose and small-dose groups were gavaged with 39.6 g/kg and 19. 8 g/kg Yushen Formula, and the blank group and model group were gavaged with the same amount of drinking wa- ter for 21 days. The 24 h urine volume and 24 h urinary protein (24 hUP), renal function, blood lipids, total protein (TP), kidney tissue endothelin-1 (ET-1) and renal pathological changes were compared in all groups. Results Comparing with the model group, the 24 h urine volumes were significantly increased in the hormone group and Yushen Formula large-dose and small-dose groups, but the 24 hUP was significantly decreased in Yushen Formula large-dose and small-dose groups ( P 〈 0.05 or P 〈 0.01 ). Comparing with the blank group, the renal function and blood lipids were significantly increased but TP was significantly decreased in other groups ( P 〈 0. 05 or P 〈 0.01 ). Comparing with the blank group, the staining intensity of kidney tissue ET-1 was significantly increased in the model group but decreased in Yushen Formula large-dose and small-dose groups. Conclusion Yushen Formula can obviously reduce urinary protein and repair glomerular structure, podocyte and slit diaphragm in AN rats. Its mechanism may be associ- ated with reduced secretion of ET-1.
出处 《中医杂志》 CSCD 北大核心 2014年第11期959-963,共5页 Journal of Traditional Chinese Medicine
基金 中国中医科学院望京医院院级课题(WJ2011-26)
关键词 肾病综合征 愈肾方 阿霉素 尿蛋白 内皮素1 nephrotic syndrome Yushen Formula adriamycin urinary protein endothelin-1
  • 相关文献

参考文献7

  • 1Remuzzi G,Bertani T.Pathophysiology of progressive nephropathies[J].N Engl J Med,1998,339(20):1448-1456.
  • 2王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2009:993.
  • 3Bertani T,Poggi A,Pozzoni R,et al.Adrimycin induced nephritic syndrome in rats:sequence of pathologic events[J].Lab Invest,1982,46(1):16-23.
  • 4王泰华,钱家麒,张介玉,姚莒华.阿霉素肾病肾硬化动物模型的实验改进[J].肾脏病与透析肾移植杂志,1997,6(2):191-193. 被引量:47
  • 5支勇,曹式丽.阿霉素肾病动物模型的国外研究进展[J].中国中西医结合肾病杂志,2008,9(10):933-935. 被引量:29
  • 6Oka Y,Tsuboi A,Fujiki F,et al.“Cancer antigen WT1protein-derived peptide”-based treatment of cancer-toward the further development[J].Curr Med Chem,2008,15(29):3052-3061.
  • 7NisticòP,Capone I,Palermo B,et al.Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients[J].Int J Cancer,2009,124(1):130-139.

二级参考文献30

  • 1周春华,章友康,王海燕,邹万忠,鄂洁.肾小球硬化及老年肾细胞外基质的变化研究[J].中华肾脏病杂志,1994,10(3):152-155. 被引量:14
  • 2Deschenes G,Doucet A. Collecting Duct Na^+/K^+ - ATPase Activity is correlated with urinary sodium excretion in rat nephrotic syndromes. J Am Soc Nephrol,2000,11 (4) :604 - 615.
  • 3Venkatesan N, Punithavathi D, Arumugam V. Curcurnin prevents adriamycin nephrotoxicity in rats. Br J Pharmacol, 2000, 129(2) :231 - 234.
  • 4De Boer ED, Navis G, Tiebosch ATM, et al. Systemic factors are involved in the pathogenesis of proteinuriainduced glomemlosclerosis in adriamycin nephrotic rats. J Am Soc Nephrol, 1999,10(11) :2359 - 2366.
  • 5Cheng HF,Wang S, Jo YI, et al. Overexpression of cyclooxygenase-2 predisposes to podocyte injury. J Am Soc Nephrol, 2007,18(2) :551 - 559.
  • 6Fogo AB. Animal models of FSGS: lessons for pathogenesis and treatment. Semin Nephrol,2003,23(2) :161 171.
  • 7Zheng ZY, Schmidt - Ott KM, Chua S, et at. A Mendelian locus on chromosome 16 determines susceptibility to doxorubicin nephropathy in the mouse. Proc Natl Acad Sci USA, 2005, 102 (7) :2502 - 2507.
  • 8Wang Y, Wang YP, Tay YC, et al.Progressive adriamydn nephropathy in mice: Sequence of histologic and immunohistcchemical events. Kidney Int,2000,58(4) : 1797 - 1804.
  • 9Mahajan D, Wang YP, Qin XH, et al. CD4^+ CD25^+ regulatory T cells protect against injury in an innate murine model of chronic kidney disease. J Am Soc Nephrol,2006,17(10) :2731 2741.
  • 10Amore A, Mazzucco G, Cavallo F, et al. Adriamycin - induced proteinuria in nude mice: aninunune - system- mediated toxic effect. Nephrol Dial Transplant, 1996, 11 (6) : 1012 - 1018.

共引文献128

同被引文献9

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部